Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems

Infect Immun. 2005 Sep;73(9):5654-65. doi: 10.1128/IAI.73.9.5654-5665.2005.

Abstract

Noninvasive mucosal vaccines are attractive alternatives to parenteral vaccines. Although the conjugation of vaccine antigens with the B subunit of cholera toxin (CTB) is one of the most promising strategies for vaccine delivery to mucosal immune systems, the molecule cannot tolerate large-protein fusion, as it severely impairs pentamerization and loses affinity for GM1-ganglioside. Here we report a new strategy, in which steric hindrance between CTB-antigen fusion subunits is significantly reduced through the integration of unfused CTB "molecular buffers" into the pentamer unit, making them more efficiently self-assemble into biologically active pentamers. In addition, the chimeric protein took a compact configuration, becoming small enough to be secreted, and one-step affinity-purified proteins, when administered through a mucosal route, induced specific immune responses in mice. Since our results are not dependent on the use of a particular expression system or vaccine antigen, this strategy could be broadly applicable to bacterial enterotoxin-based vaccine design.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cholera / immunology
  • Cholera / prevention & control*
  • Cholera Toxin / genetics
  • Cholera Toxin / immunology*
  • Immunity, Mucosal
  • Mice
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / immunology*
  • Vaccines, Subunit / genetics
  • Vaccines, Subunit / immunology
  • Vaccines, Synthetic / genetics
  • Vaccines, Synthetic / immunology

Substances

  • Recombinant Fusion Proteins
  • Vaccines, Subunit
  • Vaccines, Synthetic
  • Cholera Toxin